Fortrea Holdings Inc. (FTRE)
USD 6.26
(2.96%)
USD 6.26
(2.96%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1.67 Billion USD | 2546.69% |
| 2022 | 63.4 Million USD | -17.88% |
| 2021 | 77.2 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 1.2 Billion USD | -28.77% |
| 2024 Q1 | 1.68 Billion USD | 0.66% |
| 2023 Q4 | 1.67 Billion USD | -0.48% |
| 2023 Q3 | 1.68 Billion USD | 0.48% |
| 2023 Q1 | 1.66 Billion USD | 2523.66% |
| 2023 Q2 | 1.67 Billion USD | 0.88% |
| 2023 FY | 1.67 Billion USD | 2546.69% |
| 2022 Q4 | 63.4 Million USD | 0.0% |
| 2022 FY | 63.4 Million USD | -17.88% |
| 2021 FY | 77.2 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| NeuroSense Therapeutics Ltd. | 142 Thousand USD | -1181590.141% |
| Psyence Biomedical Ltd. | 7.65 Million USD | -21813.452% |
| XOMA Corporation | 124.45 Million USD | -1248.333% |
| Mesoblast Limited | 118.92 Million USD | -1310.997% |
| Xeris Biopharma Holdings, Inc. | 229.19 Million USD | -632.14% |
| Aptorum Group Limited | 3.36 Million USD | -49804.874% |
| Qualigen Therapeutics, Inc. | 1.29 Million USD | -129054.813% |
| HilleVax, Inc. | 51.19 Million USD | -3177.792% |
| Rocket Pharmaceuticals, Inc. | 25.04 Million USD | -6600.743% |
| Corbus Pharmaceuticals Holdings, Inc. | 20.88 Million USD | -7934.77% |
| Precision BioSciences, Inc. | 31.26 Million USD | -5266.509% |
| Dyadic International, Inc. | 136.92 Thousand USD | -1225352.607% |
| Intensity Therapeutics, Inc. | 158 Thousand USD | -1061925.316% |
| IDEAYA Biosciences, Inc. | 2.87 Million USD | -58326.184% |
| Eton Pharmaceuticals, Inc. | 5.45 Million USD | -30660.77% |
| VYNE Therapeutics Inc. | 214 Thousand USD | -784012.15% |
| EyePoint Pharmaceuticals, Inc. | 5.46 Million USD | -30582.026% |
| Adaptive Biotechnologies Corporation | 229.43 Million USD | -631.371% |
| Tenaya Therapeutics, Inc. | 12.42 Million USD | -13406.117% |
| IGM Biosciences, Inc. | 40.5 Million USD | -4042.596% |
| Opthea Limited | 200.62 Million USD | -736.37% |
| Milestone Pharmaceuticals Inc. | 51.77 Million USD | -3140.946% |
| Abeona Therapeutics Inc. | 5.4 Million USD | -30974.074% |
| Tonix Pharmaceuticals Holding Corp. | 9.81 Million USD | -16999.766% |
| Ligand Pharmaceuticals Incorporated | 6.16 Million USD | -27118.167% |
| NextCure, Inc. | 6.6 Million USD | -25304.996% |
| Inhibikase Therapeutics, Inc. | 622 Thousand USD | -269673.618% |
| Ovid Therapeutics Inc. | 46 Million USD | -3547.689% |
| CASI Pharmaceuticals, Inc. | 21.23 Million USD | -7800.56% |
| Arcturus Therapeutics Holdings Inc. | 30.21 Million USD | -5453.349% |
| Syros Pharmaceuticals, Inc. | 62.07 Million USD | -2603.182% |
| Senti Biosciences, Inc. | 37.66 Million USD | -4354.946% |
| Apollomics, Inc. | 4.66 Million USD | -35900.858% |
| PureTech Health plc | 25.51 Million USD | -6477.297% |
| Oncternal Therapeutics, Inc. | 318 Thousand USD | -527572.956% |
| Barinthus Biotherapeutics plc | 12.97 Million USD | -12831.567% |
| Kymera Therapeutics, Inc. | 84.67 Million USD | -1881.718% |
| ChromaDex Corporation | 3.27 Million USD | -51105.371% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Akebia Therapeutics, Inc. | 104.18 Million USD | -1510.643% |
| Sangamo Therapeutics, Inc. | 38.1 Million USD | -4303.737% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | 104.77 Million USD | -1501.527% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Fate Therapeutics, Inc. | 103.53 Million USD | -1520.692% |
| BioXcel Therapeutics, Inc. | 101.38 Million USD | -1555.094% |
| Fortress Biotech, Inc. | 88.59 Million USD | -1794.076% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| Lyell Immunopharma, Inc. | 63.16 Million USD | -2556.45% |
| Celcuity Inc. | 37.44 Million USD | -4381.086% |
| ContextLogic Inc. | 6 Million USD | -27866.667% |
| GH Research PLC | 343 Thousand USD | -489112.828% |
| HOOKIPA Pharma Inc. | 6.55 Million USD | -25483.168% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -4535035.135% |
| ImmuCell Corporation | 11.96 Million USD | -13919.196% |
| Amarin Corporation plc | 8.73 Million USD | -19105.677% |
| TG Therapeutics, Inc. | 110.79 Million USD | -1414.509% |
| X4 Pharmaceuticals, Inc. | 58.28 Million USD | -2779.154% |
| Acelyrin, Inc. | 1.19 Million USD | -140436.013% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Seer, Inc. | 28.25 Million USD | -5837.931% |
| Novavax, Inc. | 280.63 Million USD | -497.93% |
| Phathom Pharmaceuticals, Inc. | 139.03 Million USD | -1106.934% |
| Jazz Pharmaceuticals plc | 5.79 Billion USD | 71.052% |
| AnaptysBio, Inc. | 17.81 Million USD | -9319.558% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -30991.347% |
| PMV Pharmaceuticals, Inc. | 13.28 Million USD | -12529.836% |
| AbCellera Biologics Inc. | 77.38 Million USD | -2068.519% |
| CorMedix Inc. | 667.63 Thousand USD | -251236.065% |
| Cartesian Therapeutics, Inc. | 10.95 Million USD | -15217.207% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 37.919% |
| Aptose Biosciences Inc. | 1 Million USD | -166070.532% |
| ZyVersa Therapeutics, Inc. | 8656.00 USD | -19385297.412% |
| Soligenix, Inc. | 3.49 Million USD | -47917.476% |
| Century Therapeutics, Inc. | 48.17 Million USD | -3383.424% |
| Arrowhead Pharmaceuticals, Inc. | 115.17 Million USD | -1356.964% |
| TransCode Therapeutics, Inc. | 450.57 Thousand USD | -372316.334% |
| Kura Oncology, Inc. | 17.2 Million USD | -9655.814% |
| RAPT Therapeutics, Inc. | 6.9 Million USD | -24197.712% |
| Ardelyx, Inc. | 55.98 Million USD | -2897.392% |
| Ainos, Inc. | 5.96 Million USD | -28037.574% |
| TScan Therapeutics, Inc. | 92.43 Million USD | -1715.369% |
| Ocean Biomedical, Inc. | 2.15 Million USD | -77946.512% |
| Prothena Corporation plc | 11.83 Million USD | -14078.285% |
| CytomX Therapeutics, Inc. | 13.97 Million USD | -11908.015% |
| Autolus Therapeutics plc | 52.96 Million USD | -3068.01% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| Adaptimmune Therapeutics plc | 25.23 Million USD | -6549.495% |
| Eterna Therapeutics Inc. | 41.84 Million USD | -3910.229% |
| Celularity Inc. | 65.41 Million USD | -2465.082% |
| Rallybio Corporation | 392 Thousand USD | -427961.224% |
| GRI Bio, Inc. | 14 Thousand USD | -11985614.286% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Omeros Corporation | 338.28 Million USD | -396.037% |
| INmune Bio, Inc. | 10.43 Million USD | -15977.417% |
| Heron Therapeutics, Inc. | 179.62 Million USD | -834.153% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -28306.691% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -2054258.472% |
| Entero Therapeutics, Inc. | 826.84 Thousand USD | -202840.337% |
| Humacyte, Inc. | 58.1 Million USD | -2787.826% |
| Atara Biotherapeutics, Inc. | 57.87 Million USD | -2799.502% |
| Coherus BioSciences, Inc. | 480.84 Million USD | -248.971% |
| Immunocore Holdings plc | 84.03 Million USD | -1896.858% |
| Cocrystal Pharma, Inc. | 1.85 Million USD | -90455.855% |
| Verastem, Inc. | 41.55 Million USD | -3937.828% |
| Pliant Therapeutics, Inc. | 11.37 Million USD | -14655.54% |
| Histogen Inc. | 4.62 Million USD | -36204.63% |
| Surrozen, Inc. | 3.37 Million USD | -49559.663% |
| Blueprint Medicines Corporation | 774.12 Million USD | -116.762% |
| Organovo Holdings, Inc. | 1.39 Million USD | -120273.027% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| IO Biotech, Inc. | 2.49 Million USD | -67181.476% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| GT Biopharma, Inc. | 58 Thousand USD | -2893003.448% |
| Centessa Pharmaceuticals plc | 84.58 Million USD | -1883.733% |
| Hepion Pharmaceuticals, Inc. | 209.02 Thousand USD | -802693.991% |
| Cabaletta Bio, Inc. | 5.01 Million USD | -33339.617% |
| Summit Therapeutics Inc. | 106.09 Million USD | -1481.542% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 110.35 Million USD | -1420.506% |
| BioRestorative Therapies, Inc. | 162.31 Thousand USD | -1033679.579% |
| Turnstone Biologics Corp. | 3.21 Million USD | -52109.085% |
| Pulmatrix, Inc. | 8.75 Million USD | -19064.002% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 247 Thousand USD | -679252.227% |
| Aurinia Pharmaceuticals Inc. | 97.6 Million USD | -1619.139% |
| Vigil Neuroscience, Inc. | 13.85 Million USD | -12015.523% |
| Intellia Therapeutics, Inc. | 115.34 Million USD | -1354.754% |
| Cytokinetics, Incorporated | 755.77 Million USD | -122.025% |
| Exelixis, Inc. | 189.94 Million USD | -783.418% |
| Nurix Therapeutics, Inc. | 30.61 Million USD | -5381.152% |
| Apellis Pharmaceuticals, Inc. | 110.92 Million USD | -1412.693% |
| Evogene Ltd. | 1.13 Million USD | -147351.67% |
| Replimune Group, Inc. | 75.86 Million USD | -2111.707% |
| PDS Biotechnology Corporation | 23.85 Million USD | -6935.162% |
| Hoth Therapeutics, Inc. | 55.16 Thousand USD | -3041683.74% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -60129.72% |
| ESSA Pharma Inc. | 80.32 Thousand USD | -2088835.365% |
| TNF Pharmaceuticals, Inc. | 48.87 Thousand USD | -3433499.345% |
| BioLineRx Ltd. | 11.59 Million USD | -14376.749% |
| Avid Bioservices, Inc. | 207.83 Million USD | -707.375% |
| Insmed Incorporated | 1.2 Billion USD | -39.369% |
| VistaGen Therapeutics, Inc. | 2.12 Million USD | -79050.943% |
| Zentalis Pharmaceuticals, Inc. | 45.77 Million USD | -3565.917% |
| Sagimet Biosciences Inc. | 65 Thousand USD | -2581438.462% |
| MediWound Ltd. | 6.71 Million USD | -24903.725% |
| MiMedx Group, Inc. | 48.09 Million USD | -3388.638% |
| OmniAb, Inc. | 25.56 Million USD | -6464.688% |
| Alector, Inc. | 38.91 Million USD | -4211.63% |
| Seres Therapeutics, Inc. | 213.93 Million USD | -684.347% |
| PTC Therapeutics, Inc. | 415.02 Million USD | -304.312% |
| Mereo BioPharma Group plc | 5.95 Million USD | -28092.204% |
| Zai Lab Limited | 15.15 Million USD | -10975.177% |
| Revance Therapeutics, Inc. | 478.43 Million USD | -250.728% |
| Syndax Pharmaceuticals, Inc. | 1.63 Million USD | -102529.969% |
| Aura Biosciences, Inc. | 19.55 Million USD | -8480.048% |
| Immunic, Inc. | 1.33 Million USD | -125687.106% |
| Dyne Therapeutics, Inc. | 27.41 Million USD | -6020.737% |
| Tarsus Pharmaceuticals, Inc. | 31.73 Million USD | -5188.037% |
| Veracyte, Inc. | 12.63 Million USD | -13185.827% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | -160.21% |
| FibroGen, Inc. | 170.45 Million USD | -884.424% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -18378.141% |
| Allakos Inc. | 41.46 Million USD | -3946.786% |
| scPharmaceuticals Inc. | 40.26 Million USD | -4066.977% |
| Fulcrum Therapeutics, Inc. | 10.82 Million USD | -15406.885% |
| Corcept Therapeutics Incorporated | 151 Thousand USD | -1111158.278% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| NLS Pharmaceutics AG | 1.63 Million USD | -102608.744% |
| Sonnet BioTherapeutics Holdings, Inc. | 203.91 Thousand USD | -822808.033% |
| Amylyx Pharmaceuticals, Inc. | 4.23 Million USD | -39503.493% |
| Precigen, Inc. | 7.09 Million USD | -23543.793% |
| KalVista Pharmaceuticals, Inc. | 7.31 Million USD | -22832.896% |
| Incyte Corporation | 38.28 Million USD | -4282.689% |
| Alzamend Neuro, Inc. | 300.71 Thousand USD | -557905.281% |
| Cara Therapeutics, Inc. | 43.16 Million USD | -3787.229% |
| XBiotech Inc. | - USD | -Infinity% |
| Aligos Therapeutics, Inc. | 11.13 Million USD | -14965.541% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -60129.72% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| CRISPR Therapeutics AG | 238.63 Million USD | -603.175% |
| Akero Therapeutics, Inc. | 26.04 Million USD | -6343.19% |
| Eliem Therapeutics, Inc. | 349 Thousand USD | -480702.292% |
| Lyra Therapeutics, Inc. | 26.88 Million USD | -6142.327% |
| Foghorn Therapeutics Inc. | 45.07 Million USD | -3622.85% |
| Agenus Inc. | 350.24 Million USD | -379.092% |
| Kiora Pharmaceuticals, Inc. | 106.89 Thousand USD | -1569723.465% |
| Y-mAbs Therapeutics, Inc. | 1.41 Million USD | -118152.29% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -3609.435% |
| Ultragenyx Pharmaceutical Inc. | 43.16 Million USD | -3787.049% |
| Metagenomi, Inc. Common Stock | 48.22 Million USD | -3379.234% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -1023276.655% |
| BioCryst Pharmaceuticals, Inc. | 848.71 Million USD | -97.711% |
| UroGen Pharma Ltd. | 100.21 Million USD | -1574.417% |
| Gain Therapeutics, Inc. | 1.02 Million USD | -163225.216% |
| Sutro Biopharma, Inc. | 182.74 Million USD | -818.199% |
| Creative Medical Technology Holdings, Inc. | 14.19 Thousand USD | -11821796.576% |
| Lisata Therapeutics, Inc. | 305 Thousand USD | -550063.934% |
| Chemomab Therapeutics Ltd. | 392 Thousand USD | -427959.041% |
| Stoke Therapeutics, Inc. | 6.83 Million USD | -24450.11% |
| Chimerix, Inc. | 2.14 Million USD | -78164.925% |
| Reneo Pharmaceuticals, Inc. | 973 Thousand USD | -172356.321% |
| Outlook Therapeutics, Inc. | 35.55 Million USD | -4619.413% |
| 60 Degrees Pharmaceuticals, Inc. | 172.67 Thousand USD | -971679.027% |
| Pluri Inc. | 29.61 Million USD | -5566.622% |
| Cue Biopharma, Inc. | 14.69 Million USD | -11318.85% |
| MeiraGTx Holdings plc | 89.26 Million USD | -1779.817% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Cadrenal Therapeutics, Inc. Common Stock | 21.35 Thousand USD | -7859384.778% |
| Cidara Therapeutics, Inc. | 4.87 Million USD | -34306.397% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Scholar Rock Holding Corporation | 61.81 Million USD | -2614.42% |
| Sana Biotechnology, Inc. | 104.09 Million USD | -1511.974% |
| Elicio Therapeutics, Inc. | 6.91 Million USD | -24159.072% |
| NLS Pharmaceutics AG | 1.63 Million USD | -102608.744% |
| Adlai Nortye Ltd. American Depositary Shares | 31.54 Million USD | -5218.878% |
| Nutriband Inc. | 241.28 Thousand USD | -695343.148% |
| Protara Therapeutics, Inc. | 5.46 Million USD | -30593.25% |
| Vor Biopharma Inc. | 35.66 Million USD | -4605.552% |
| Roivant Sciences Ltd. | 499.74 Million USD | -235.769% |
| ProKidney Corp. | 4.41 Million USD | -37924.02% |
| Applied Therapeutics, Inc. | 1.22 Million USD | -136767.863% |
| Daré Bioscience, Inc. | 5.31 Million USD | -31452.355% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 3.554% |
| Titan Pharmaceuticals, Inc. | 565 Thousand USD | -296891.15% |
| Bicycle Therapeutics plc | 44.95 Million USD | -3632.538% |
| Tango Therapeutics, Inc. | 38.92 Million USD | -4211.408% |
| Galectin Therapeutics Inc. | 71.8 Million USD | -2236.82% |
| Revolution Medicines, Inc. Warrant | 87.94 Million USD | -1808.032% |
| Atai Life Sciences N.V. | 16.47 Million USD | -10084.511% |
| Renovaro Biosciences Inc. | 2.45 Million USD | -68361.964% |
| Aerovate Therapeutics, Inc. | 675 Thousand USD | -248492.593% |
| MediciNova, Inc. | 215.92 Thousand USD | -777018.087% |
| Praxis Precision Medicines, Inc. | 2.49 Million USD | -67154.509% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -132966.038% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Protagonist Therapeutics, Inc. | 1.14 Million USD | -146963.979% |
| Axsome Therapeutics, Inc. | 186.37 Million USD | -800.35% |
| Biomea Fusion, Inc. | 10.29 Million USD | -16197.591% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Erasca, Inc. | 55.85 Million USD | -2903.992% |
| Cullinan Oncology, Inc. | 3.59 Million USD | -46640.947% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -18216.778% |
| 4D Molecular Therapeutics, Inc. | 14.67 Million USD | -11337.53% |
| Kiniksa Pharmaceuticals, Ltd. | 12.25 Million USD | -13589.019% |
| bluebird bio, Inc. | 330.32 Million USD | -407.983% |
| Ventyx Biosciences, Inc. | 12.5 Million USD | -13317.56% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| Imunon, Inc. | 1.62 Million USD | -103179.716% |
| BioMarin Pharmaceutical Inc. | 1.13 Billion USD | -47.988% |
| BioAtla, Inc. | 2.46 Million USD | -68111.382% |
| Allogene Therapeutics, Inc. | 95.12 Million USD | -1664.069% |
| Larimar Therapeutics, Inc. | 5.54 Million USD | -30156.04% |
| DBV Technologies S.A. | 14.38 Million USD | -11568.173% |
| Fortress Biotech, Inc. | 88.59 Million USD | -1794.076% |
| Avidity Biosciences, Inc. | 9.85 Million USD | -16932.075% |
| Kezar Life Sciences, Inc. | 18.93 Million USD | -8762.832% |
| aTyr Pharma, Inc. | 15.09 Million USD | -11016.264% |
| Viridian Therapeutics, Inc. | 21.04 Million USD | -7872.254% |
| EyeGate Pharmaceuticals, Inc. | 326.49 Thousand USD | -513846.7% |
| Galecto, Inc. | 249 Thousand USD | -673795.582% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -102735.956% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | -11.923% |
| Lexicon Pharmaceuticals, Inc. | 106.06 Million USD | -1482.064% |
| Entera Bio Ltd. | 390 Thousand USD | -430156.41% |
| Travere Therapeutics, Inc. | 404.78 Million USD | -314.542% |
| Sensei Biotherapeutics, Inc. | 6.2 Million USD | -26929.639% |
| Xencor, Inc. | 83.43 Million USD | -1911.171% |
| Orchestra BioMed Holdings, Inc. | 1.68 Million USD | -99366.509% |
| Spruce Biosciences, Inc. | 4.6 Million USD | -36307.03% |
| Coeptis Therapeutics Holdings, Inc. | 1.22 Million USD | -136966.195% |
| Vanda Pharmaceuticals Inc. | 9.4 Million USD | -17743.471% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -1023276.655% |
| Portage Biotech Inc. | 47 Thousand USD | -3570112.766% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -132966.038% |
| Olema Pharmaceuticals, Inc. | 2.41 Million USD | -69324.907% |
| OncoCyte Corporation | 2.86 Million USD | -58387.278% |
| Processa Pharmaceuticals, Inc. | 150.55 Thousand USD | -1114450.261% |
| Purple Biotech Ltd. | 351 Thousand USD | -477962.678% |
| CollPlant Biotechnologies Ltd. | 3.15 Million USD | -53018.075% |
| Onconetix, Inc. | 9.88 Million USD | -16873.889% |
| MacroGenics, Inc. | 33.97 Million USD | -4839.507% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Apogee Therapeutics, Inc. | 2.03 Million USD | -82397.582% |
| Neumora Therapeutics, Inc. Common Stock | 5.23 Million USD | -31977.997% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Prime Medicine, Inc. | 13.63 Million USD | -12208.369% |
| Aditxt, Inc. | 18.21 Million USD | -9110.677% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.73 Million USD | -6175.712% |
| Curis, Inc. | 2.79 Million USD | -59957.266% |
| Carmell Therapeutics Corporation | 2.13 Million USD | -78441.543% |
| Adagene Inc. | 22.3 Million USD | -7422.346% |
| Achieve Life Sciences, Inc. | 16.73 Million USD | -9929.287% |
| BeiGene, Ltd. | 930.18 Million USD | -80.394% |
| Inhibrx Biosciences, Inc. | 210.14 Million USD | -698.511% |
| GlycoMimetics, Inc. | 808.4 Thousand USD | -207469.996% |
| Maravai LifeSciences Holdings, Inc. | 610.96 Million USD | -174.647% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| SciSparc Ltd. | 76 Thousand USD | -2207794.737% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 2.5 Million USD | -66966.347% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -1945.922% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Arcutis Biotherapeutics, Inc. | 205.91 Million USD | -714.895% |
| Acrivon Therapeutics, Inc. Common Stock | 4.64 Million USD | -36032.644% |
| Alnylam Pharmaceuticals, Inc. | 2.68 Billion USD | 37.449% |
| ADMA Biologics, Inc. | 141.41 Million USD | -1086.553% |
| Rigel Pharmaceuticals, Inc. | 60.57 Million USD | -2669.937% |
| Clene Inc. | 32.16 Million USD | -5117.499% |
| Celldex Therapeutics, Inc. | 2.54 Million USD | -65911.015% |
| Cogent Biosciences, Inc. | 18.85 Million USD | -8800.44% |
| Boundless Bio, Inc. Common Stock | 2.19 Million USD | -76346.469% |
| Recursion Pharmaceuticals, Inc. | 50.67 Million USD | -3211.494% |
| Adicet Bio, Inc. | 20.92 Million USD | -7919.499% |
| Contineum Therapeutics, Inc. Class A Common Stock | 193.19 Million USD | -768.566% |
| Absci Corporation | 15.95 Million USD | -10415.761% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 15.3 Million USD | -10865.17% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 20.29 Million USD | -8168.861% |
| Surrozen, Inc. | 3.37 Million USD | -49559.663% |
| Generation Bio Co. | 97.89 Million USD | -1614.099% |
| Astria Therapeutics, Inc. | 329 Thousand USD | -509930.395% |
| Caribou Biosciences, Inc. | 27.48 Million USD | -6005.148% |
| Black Diamond Therapeutics, Inc. | 25.29 Million USD | -6532.935% |
| Janux Therapeutics, Inc. | 24.54 Million USD | -6737.259% |
| Invivyd, Inc. | 2.16 Million USD | -77405.774% |
| Cingulate Inc. | 3.13 Million USD | -53423.031% |
| Relay Therapeutics, Inc. | 53.46 Million USD | -3038.443% |
| Quoin Pharmaceuticals, Ltd. | 3523.73 USD | -47619893.586% |
| Tenax Therapeutics, Inc. | 500.9 Thousand USD | -334894.999% |
| Spero Therapeutics, Inc. | 5.54 Million USD | -30172.416% |
| Jaguar Health, Inc. | 35.86 Million USD | -4579.308% |
| Artelo Biosciences, Inc. | 63 Thousand USD | -2663392.063% |
| 2seventy bio, Inc. | 256.67 Million USD | -553.75% |
| Clearside Biomedical, Inc. | 43 Million USD | -3802.235% |
| Terns Pharmaceuticals, Inc. | 603 Thousand USD | -278175.29% |
| ACADIA Pharmaceuticals Inc. | 57.2 Million USD | -2833.31% |
| Capricor Therapeutics, Inc. | 5.61 Million USD | -29799.393% |
| Citius Pharmaceuticals, Inc. | 481.24 Thousand USD | -348578.947% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 28.27 Million USD | -5835.201% |
| Innoviva, Inc. | 449.07 Million USD | -273.656% |
| Bolt Biotherapeutics, Inc. | 20.21 Million USD | -8199.125% |
| Entrada Therapeutics, Inc. | 68.23 Million USD | -2359.329% |
| ALX Oncology Holdings Inc. | 17.19 Million USD | -9657.516% |
| Vir Biotechnology, Inc. | 124.54 Million USD | -1247.358% |
| Evaxion Biotech A/S | 10.86 Million USD | -15337.438% |
| Ocular Therapeutix, Inc. | 83.38 Million USD | -1912.256% |
| Verve Therapeutics, Inc. | 74.9 Million USD | -2140.111% |
| Tyra Biosciences, Inc. | 6.49 Million USD | -25731.281% |
| Galmed Pharmaceuticals Ltd. | 41 Thousand USD | -4092582.927% |
| Unity Biotechnology, Inc. | 26.99 Million USD | -6117.117% |
| Connect Biopharma Holdings Limited | 465 Thousand USD | -360760.215% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| AlloVir, Inc. | 27.42 Million USD | -6017.613% |
| ORIC Pharmaceuticals, Inc. | 10.21 Million USD | -16330.04% |
| Catalyst Pharmaceuticals, Inc. | 3.55 Million USD | -47074.585% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -107809.968% |
| Viking Therapeutics, Inc. | 1.26 Million USD | -133074.603% |
| Keros Therapeutics, Inc. | 14.44 Million USD | -11517.281% |
| SELLAS Life Sciences Group, Inc. | 906 Thousand USD | -185109.713% |
| Crinetics Pharmaceuticals, Inc. | 51.72 Million USD | -3143.891% |
| ImmunityBio, Inc. | 883.67 Million USD | -89.888% |
| Korro Bio, Inc. | 33.2 Million USD | -4953.151% |
| C4 Therapeutics, Inc. | 70.97 Million USD | -2264.179% |
| Kineta, Inc. | 1.31 Million USD | -127310.782% |
| Lantern Pharma Inc. | 234.47 Thousand USD | -715553.535% |
| BioVie Inc. | 6.11 Million USD | -27356.673% |
| Codexis, Inc. | 22.36 Million USD | -7403.13% |
| Celularity Inc. | 65.41 Million USD | -2465.082% |
| Eledon Pharmaceuticals, Inc. | 383 Thousand USD | -438020.104% |
| Virax Biolabs Group Limited | 224.3 Thousand USD | -748005.216% |
| Kodiak Sciences Inc. | 181.63 Million USD | -823.846% |
| Cibus, Inc. | 24.62 Million USD | -6715.32% |
| Annexon, Inc. | 31.35 Million USD | -5251.619% |
| Assembly Biosciences, Inc. | 2.34 Million USD | -71548.164% |
| Moderna, Inc. | - USD | -Infinity% |
| Ionis Pharmaceuticals, Inc. | 1.45 Billion USD | -15.442% |
| Adverum Biotechnologies, Inc. | 75.03 Million USD | -2136.26% |
| Avalo Therapeutics, Inc. | 3.9 Million USD | -42892.57% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Eyenovia, Inc. | 16.1 Million USD | -10317.34% |
| Puma Biotechnology, Inc. | 111.49 Million USD | -1405.068% |
| Monte Rosa Therapeutics, Inc. | 46.03 Million USD | -3544.736% |
| Wave Life Sciences Ltd. | 32.11 Million USD | -5124.485% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -170255.33% |
| Xilio Therapeutics, Inc. | 11.45 Million USD | -14546.068% |
| Alkermes plc | 290.73 Million USD | -477.168% |
| Arcellx, Inc. | 97.62 Million USD | -1618.822% |
| Moolec Science SA | 2.64 Million USD | -63333.523% |
| Cardiff Oncology, Inc. | 2.14 Million USD | -77982.829% |
| LAVA Therapeutics N.V. | 6.31 Million USD | -26480.073% |
| Enanta Pharmaceuticals, Inc. | 26.51 Million USD | -6228.971% |
| Regulus Therapeutics Inc. | 3.1 Million USD | -53994.133% |
| Atea Pharmaceuticals, Inc. | 2.4 Million USD | -69758.451% |
| Compass Therapeutics, Inc. | 1.73 Million USD | -96726.313% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| Humacyte, Inc. | 58.1 Million USD | -2787.826% |
| Acumen Pharmaceuticals, Inc. | 28.48 Million USD | -5790.406% |
| Geron Corporation | 85.89 Million USD | -1853.457% |
| Verrica Pharmaceuticals Inc. | 45.51 Million USD | -3587.102% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Royalty Pharma plc | 6.13 Billion USD | 72.65% |
| TFF Pharmaceuticals, Inc. | 115.25 Thousand USD | -1455814.762% |
| Notable Labs, Ltd. | 2.04 Million USD | -81793.607% |
| Mersana Therapeutics, Inc. | 33.83 Million USD | -4860.095% |
| Structure Therapeutics Inc. | 5.45 Million USD | -30672.046% |
| IN8bio, Inc. | 4.89 Million USD | -34193.889% |
| 89bio, Inc. | 27.1 Million USD | -6090.055% |
| DiaMedica Therapeutics Inc. | 400 Thousand USD | -419400.0% |
| Vera Therapeutics, Inc. | 53.7 Million USD | -3024.302% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| Genelux Corporation | 2.51 Million USD | -66513.736% |
| Trevi Therapeutics, Inc. | 1.33 Million USD | -125311.061% |
| Liquidia Corporation | 3.5 Million USD | -47801.798% |
| Mustang Bio, Inc. | 2.49 Million USD | -67073.739% |
| Immunovant, Inc. | 138 Thousand USD | -1215842.029% |
| Vericel Corporation | 88.14 Million USD | -1803.725% |
| Quantum-Si incorporated | 15.3 Million USD | -10865.17% |
| Arbutus Biopharma Corporation | 8.72 Million USD | -19140.913% |
| XOMA Corporation | 124.45 Million USD | -1248.333% |
| ARS Pharmaceuticals, Inc. | 274 Thousand USD | -612308.759% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -2054258.472% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -12539.349% |
| Vaxcyte, Inc. | 29.22 Million USD | -5641.856% |
| Xenon Pharmaceuticals Inc. | 10.9 Million USD | -15290.26% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| NeuroBo Pharmaceuticals, Inc. | 203 Thousand USD | -826500.985% |
| Tempest Therapeutics, Inc. | 20.66 Million USD | -8021.582% |
| Sol-Gel Technologies Ltd. | 1.65 Million USD | -101412.402% |
| Rhythm Pharmaceuticals, Inc. | 1.26 Million USD | -133074.603% |
| Soleno Therapeutics, Inc. | 403 Thousand USD | -416277.171% |
| Enlivex Therapeutics Ltd. | 1.03 Million USD | -162496.899% |
| PepGen Inc. | 20.1 Million USD | -8246.598% |
| Moleculin Biotech, Inc. | 574 Thousand USD | -292234.495% |
| United Therapeutics Corporation | 700 Million USD | -139.714% |
| Solid Biosciences Inc. | 26.26 Million USD | -6288.73% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -170255.33% |
| Immuneering Corporation | 4.46 Million USD | -37498.374% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | 101 Thousand USD | -1661286.139% |
| Belite Bio, Inc | 886 Thousand USD | -189290.519% |
| Pharming Group N.V. | 171.54 Million USD | -878.169% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Bionomics Limited | 239.61 Million USD | -600.281% |
| Pyxis Oncology, Inc. | 21.33 Million USD | -7766.485% |
| uniQure N.V. | 138.4 Million USD | -1112.349% |
| Windtree Therapeutics, Inc. | 16.83 Million USD | -9870.291% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 85.42 Million USD | -1864.342% |
| Altimmune, Inc. | 671 Thousand USD | -249974.516% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -12539.349% |
| Peak Bio, Inc. | 10.72 Million USD | -15550.347% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -18378.141% |
| FibroBiologics, Inc. Common Stock | 1.74 Million USD | -95950.372% |
| Benitec Biopharma Inc. | 284 Thousand USD | -590745.07% |
| Zura Bio Limited | - USD | -Infinity% |
| Amicus Therapeutics, Inc. | 445.05 Million USD | -277.029% |
| Salarius Pharmaceuticals, Inc. | 289.64 Thousand USD | -579233.87% |
| Compugen Ltd. | 1.35 Million USD | -124104.293% |
| Elevai Labs, Inc. Common Stock | 210.48 Thousand USD | -797091.302% |
| argenx SE | 20 Million USD | -8290.0% |
| Zevra Therapeutics, Inc. | 42.76 Million USD | -3823.678% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -1884.507% |
| NKGen Biotech, Inc. Common Stock | 19.92 Million USD | -8323.272% |
| Madrigal Pharmaceuticals, Inc. | 117.19 Million USD | -1331.826% |
| PolyPid Ltd. | 11.77 Million USD | -14145.691% |
| Aileron Therapeutics, Inc. | 91.45 Million USD | -1734.722% |
| Plus Therapeutics, Inc. | 4.18 Million USD | -40033.939% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Dianthus Therapeutics, Inc. | 585 Thousand USD | -286737.607% |
| Instil Bio, Inc. | 86.05 Million USD | -1849.938% |
| Elevation Oncology, Inc. | 30.13 Million USD | -5467.907% |
| Immunome, Inc. | 1.65 Million USD | -101596.97% |
| Verona Pharma plc | 51.32 Million USD | -3169.107% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| enGene Holdings Inc. Warrants | 9.77 Million USD | -17060.974% |
| Shattuck Labs, Inc. | 4.2 Million USD | -39833.365% |
| LENZ Therapeutics, Inc. | 362 Thousand USD | -463435.912% |
| Design Therapeutics, Inc. | 3.05 Million USD | -54916.393% |
| Leap Therapeutics, Inc. | 262 Thousand USD | -640358.015% |
| Seelos Therapeutics, Inc. | 14.22 Million USD | -11693.646% |
| Achilles Therapeutics plc | 4.61 Million USD | -36259.697% |
| Fractyl Health, Inc. Common Stock | 373.72 Million USD | -348.998% |
| Rani Therapeutics Holdings, Inc. | 30.09 Million USD | -5474.936% |
| MoonLake Immunotherapeutics | 3.69 Million USD | -45277.523% |
| Beam Therapeutics Inc. | 173.17 Million USD | -868.973% |
| Moolec Science SA | 2.64 Million USD | -63333.523% |
| Longboard Pharmaceuticals, Inc. | 475 Thousand USD | -353163.158% |
| AEON Biopharma, Inc. | 278 Thousand USD | -603497.122% |
| Aadi Bioscience, Inc. | 7.02 Million USD | -23789.522% |
| Enliven Therapeutics, Inc. | 335 Thousand USD | -500795.522% |
| Iovance Biotherapeutics, Inc. | 75.86 Million USD | -2111.911% |
| Taysha Gene Therapies, Inc. | 61.1 Million USD | -2646.003% |
| Inovio Pharmaceuticals, Inc. | 30.2 Million USD | -5454.592% |
| Athira Pharma, Inc. | 1.58 Million USD | -105767.508% |
| HCW Biologics Inc. | 6.45 Million USD | -25908.338% |
| XOMA Corporation | 124.45 Million USD | -1248.333% |
| NeurAxis, Inc. | 224.26 Thousand USD | -748138.652% |
| Lumos Pharma, Inc. | 6.58 Million USD | -25382.156% |
| enGene Holdings Inc. Common Stock | 9.77 Million USD | -17060.974% |
| 180 Life Sciences Corp. | 1.32 Million USD | -127014.567% |
| Nektar Therapeutics | 230.4 Million USD | -628.295% |
| NKGen Biotech, Inc. Warrants | 19.92 Million USD | -8323.272% |
| Opiant Pharmaceuticals, Inc. | 17.08 Million USD | -9724.286% |
| Arvinas, Inc. | 3.4 Million USD | -49252.941% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -107809.968% |
| Palisade Bio, Inc. | 369 Thousand USD | -454642.547% |
| Nutriband Inc. | 241.28 Thousand USD | -695343.148% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -102735.956% |
| CG Oncology, Inc. Common stock | 826 Thousand USD | -203047.7% |
| Tourmaline Bio, Inc. | 415 Thousand USD | -404237.349% |
| Merus N.V. | 12.16 Million USD | -13697.073% |
| Omega Therapeutics, Inc. | 128.42 Million USD | -1206.569% |
| Neurogene Inc. | 16.25 Million USD | -10222.978% |
| Mirum Pharmaceuticals, Inc. | 308.14 Million USD | -444.554% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| CervoMed Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 28.54 Million USD | -5779.261% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Quince Therapeutics, Inc. | 13.81 Million USD | -12047.097% |
| Rezolute, Inc. | 2.22 Million USD | -75214.183% |
| Clene Inc. | 32.16 Million USD | -5117.499% |
| Indaptus Therapeutics, Inc. | 175.05 Thousand USD | -958466.834% |
| BeyondSpring Inc. | 3.99 Million USD | -41902.503% |
| Synlogic, Inc. | 17.27 Million USD | -9613.459% |
| Allarity Therapeutics, Inc. | 1.3 Million USD | -128976.923% |
| Phio Pharmaceuticals Corp. | 35 Thousand USD | -4794185.714% |
| Peak Bio, Inc. | 10.72 Million USD | -15550.347% |
| Werewolf Therapeutics, Inc. | 51.92 Million USD | -3131.708% |
| Krystal Biotech, Inc. | 8.09 Million USD | -20631.409% |
| Karyopharm Therapeutics Inc. | 177.01 Million USD | -847.937% |
| SpringWorks Therapeutics, Inc. | 7.05 Million USD | -23677.809% |
| Lipella Pharmaceuticals Inc. | 136.59 Thousand USD | -1228358.058% |
| MannKind Corporation | 382.37 Million USD | -338.832% |
| Ikena Oncology, Inc. | 10.73 Million USD | -15526.746% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 409 Thousand USD | -410168.949% |
| Gossamer Bio, Inc. | 212.46 Million USD | -689.781% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 174 Thousand USD | -964267.816% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -18216.778% |
| Legend Biotech Corporation | 328.67 Million USD | -410.539% |
| Mural Oncology plc | 15 Million USD | -11079.959% |
| Disc Medicine, Inc. | 2.1 Million USD | -79766.73% |
| Champions Oncology, Inc. | 7.43 Million USD | -22484.118% |
| REGENXBIO Inc. | 89.29 Million USD | -1779.27% |
| Ensysce Biosciences, Inc. | 854.69 Thousand USD | -196226.885% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 552.98 Thousand USD | -303345.682% |
| Edgewise Therapeutics, Inc. | 5.41 Million USD | -30893.72% |
| Vaxart, Inc. | 26.51 Million USD | -6228.732% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 15.65 Million USD | -10617.005% |
| Cellectis S.A. | 92.85 Million USD | -1707.158% |
| Longeveron Inc. | 2.04 Million USD | -82114.601% |
| Repare Therapeutics Inc. | 3.41 Million USD | -49108.211% |
| Sarepta Therapeutics, Inc. | 1.39 Billion USD | -20.131% |
| Inozyme Pharma, Inc. | 46.59 Million USD | -3501.477% |
| Revolution Medicines, Inc. | 87.94 Million USD | -1808.032% |
| Nymox Pharmaceutical Corporation | 173 Thousand USD | -969842.197% |
| Third Harmonic Bio, Inc. | 3.95 Million USD | -42348.773% |
| ArriVent BioPharma, Inc. Common Stock | 317 Thousand USD | -529237.539% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 175 Thousand USD | -958757.143% |
| Vertex Pharmaceuticals Incorporated | 808.4 Million USD | -107.571% |
| Denali Therapeutics Inc. | 52.24 Million USD | -3112.037% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 14.4 Million USD | -11548.359% |
| Corvus Pharmaceuticals, Inc. | 1.37 Million USD | -122025.182% |
| Cingulate Inc. | 3.13 Million USD | -53423.031% |
| Passage Bio, Inc. | 26.29 Million USD | -6281.684% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.66 Million USD | -25076.294% |
| Day One Biopharmaceuticals, Inc. | 408 Thousand USD | -411174.51% |
| Oramed Pharmaceuticals Inc. | 894 Thousand USD | -187595.749% |
| Scinai Immunotherapeutics Ltd. | 20.56 Million USD | -8061.082% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 2.45 Million USD | -68358.473% |
| Carisma Therapeutics, Inc. | 3.12 Million USD | -53630.387% |
| Unicycive Therapeutics, Inc. | 811 Thousand USD | -206805.055% |
| OmniAb, Inc. | 25.56 Million USD | -6464.688% |
| Anew Medical, Inc. | 1.6 Million USD | -104448.287% |
| Fennec Pharmaceuticals Inc. | 29.58 Million USD | -5572.202% |
| Lipocine Inc. | 17.16 Thousand USD | -9775036.899% |
| Lexeo Therapeutics, Inc. Common Stock | 11.63 Million USD | -14318.285% |
| Nautilus Biotechnology, Inc. | 34.62 Million USD | -4745.79% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -28306.691% |
| G1 Therapeutics, Inc. | 57.17 Million USD | -2834.952% |
| Bellerophon Therapeutics, Inc. | 203 Thousand USD | -826500.985% |
| Sage Therapeutics, Inc. | 5.16 Million USD | -32387.899% |
| Ocugen, Inc. | 6.94 Million USD | -24075.191% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -11776.283% |
| Q32 Bio Inc. | 1.31 Million USD | -127214.112% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -249602.381% |
| Alumis Inc. Common Stock | 32.58 Million USD | -5050.399% |
| Equillium, Inc. | 824 Thousand USD | -203540.777% |
| Kyverna Therapeutics, Inc. | 9.07 Million USD | -18382.212% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | 300.8 Thousand USD | -557734.618% |
| Dominari Holdings Inc. | 3.02 Million USD | -55316.116% |
| Edesa Biotech, Inc. | 94.48 Thousand USD | -1775805.68% |
| vTv Therapeutics Inc. | 529 Thousand USD | -317102.268% |
| Bio-Techne Corporation | 419.53 Million USD | -299.964% |
| Agios Pharmaceuticals, Inc. | 71.99 Million USD | -2230.685% |
| Harmony Biosciences Holdings, Inc. | 193.56 Million USD | -766.888% |
| Prelude Therapeutics Incorporated | 16.88 Million USD | -9836.049% |
| Candel Therapeutics, Inc. | 22.76 Million USD | -7271.936% |
| iTeos Therapeutics, Inc. | 6.05 Million USD | -27598.911% |
| Nkarta, Inc. | 88.33 Million USD | -1799.501% |
| BioCardia, Inc. | 1.31 Million USD | -127504.563% |
| Iterum Therapeutics plc | 19.5 Million USD | -8501.158% |